← Leaderboards
David W Ollila
University Of North Carolina Chapel Hill
$95,068
Attributed
$95,068
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.5K · FY2005–06$100K$75K$50K$25K$0
'05
'06
Funding mix
By agency
NIH$95,068 · 2
By mechanism
M01$95,068 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Matthew J Ewend$6,239,820
- Lishan Su$24,513,865
- Wenbin Lin$10,248,495
- Stephen H Clarke$5,465,110
- Terry A Van Dyke$19,016,013
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaNeoplasm /Cancer Classification /StagingNeoplasm /Cancer ImmunotherapyCombination Cancer TherapyNeoplasm /Cancer VaccineDrug Screening /EvaluationBacillus Calmette Guerin VaccineHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer Relapse /RecurrenceClinical ResearchActive ImmunizationHuman MortalityImmune Tolerance /UnresponsivenessPlacebosPostoperative StatePatient Oriented ResearchImmune ResponseDrug Adverse Effect
Grant awards (8)
ACTIVE IMMUNOTHERAPY WITH A POLYVALENT MELANOMA VACCINE IN STAGE III$14,868
M01 · FY2006 · RR · contact PI
IMMUNOTHERAPY WITH A POLYVALENT MELANOMA VACCINE PLUS BCG IN STAGE IV$1,983
M01 · FY2006 · RR · contact PI
ACTIVE IMMUNOTHERAPY WITH A POLYVALENT MELANOMA VACCINE IN STAGE III$44,609
M01 · FY2005 · RR
IMMUNOTHERAPY WITH A POLYVALENT MELANOMA VACCINE PLUS BCG IN STAGE IV$7,854
M01 · FY2005 · RR
Active Immunotherapy with a Polyvalent Melanoma Vaccine in Stage III$22,358
M01 · FY2004 · RR
Immunotherapy with a Polyvalent Melanoma Vaccine plus BCG in Stage IV$3,396
M01 · FY2004 · RR
ACTIVE IMMUNOTHERAPY W/ BCG &MELANOMA VACCINE, CANCERVA$0
M01 · FY2000 · RR
IMMUNOTHERAPY W/ MELANOMA VACCINE PLUS BCG IN MELANOMA$0
M01 · FY2000 · RR